Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study

Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study

For patients with metastatic colorectal cancer (mCRC) that have failed a first-line oxaliplatin-based regimen, the preferred treatment option is an irinotecan-based regimen. This prospective, observational, noncomparative, post-authorization safety study (OZONE) evaluated the safety and effectivenes...

Full description

Bibliographic Details
Main Authors: Ian Chau, Marwan Fakih, Pilar García-Alfonso, Zdenĕk Linke, Ana Ruiz Casado, Eduardo Polo Marques, Pascaline Picard, Marina Celanovic, Thomas Cartwright
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cancers
Subjects:
aflibercept
antiangiogenic
clinical practice
folfiri
metastatic colorectal cancer
observational
Online Access:https://www.mdpi.com/2072-6694/12/3/657

Internet

https://www.mdpi.com/2072-6694/12/3/657

Similar Items